U.S., Nov. 5 -- An application to own the trademark for 'ZETAPRIME' has been filed on Jan. 22, 2025.
Owner(s):
Zetagen Therapeutics, Inc.; 841 East Fayette Street, Suite 1100, , NEW YORK
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of tumors and metastatic tumors; Pharmaceutical preparations for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues in the nature of tumors and metastatic tumors.
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-11-04&serialNumber=99014675
Disclaimer: Curated by HT Syndication....